ATE66211T1 - 4(5)-substituierte imidazol-derivate und zwischenverbindungen und verfahren zu ihrer herstellung. - Google Patents

4(5)-substituierte imidazol-derivate und zwischenverbindungen und verfahren zu ihrer herstellung.

Info

Publication number
ATE66211T1
ATE66211T1 AT87304304T AT87304304T ATE66211T1 AT E66211 T1 ATE66211 T1 AT E66211T1 AT 87304304 T AT87304304 T AT 87304304T AT 87304304 T AT87304304 T AT 87304304T AT E66211 T1 ATE66211 T1 AT E66211T1
Authority
AT
Austria
Prior art keywords
lower alkyl
alkyl
processes
preparation
imidazole derivatives
Prior art date
Application number
AT87304304T
Other languages
English (en)
Inventor
Arja Leena Karjalainen
Arto Johannes Karjalainen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI862039A external-priority patent/FI862039A0/fi
Priority claimed from FI870462A external-priority patent/FI870462A0/fi
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of ATE66211T1 publication Critical patent/ATE66211T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Dental Preparations (AREA)
  • Golf Clubs (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Epoxy Resins (AREA)
AT87304304T 1986-05-15 1987-05-14 4(5)-substituierte imidazol-derivate und zwischenverbindungen und verfahren zu ihrer herstellung. ATE66211T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI862039A FI862039A0 (fi) 1986-05-15 1986-05-15 Nytt foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat.
FI870462A FI870462A0 (fi) 1987-02-04 1987-02-04 Foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat.
EP87304304A EP0247764B1 (de) 1986-05-15 1987-05-14 4(5)-Substituierte Imidazol-Derivate und Zwischenverbindungen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE66211T1 true ATE66211T1 (de) 1991-08-15

Family

ID=26157963

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87304304T ATE66211T1 (de) 1986-05-15 1987-05-14 4(5)-substituierte imidazol-derivate und zwischenverbindungen und verfahren zu ihrer herstellung.

Country Status (18)

Country Link
US (2) US4933359A (de)
EP (1) EP0247764B1 (de)
JP (1) JP2561272B2 (de)
KR (1) KR950002158B1 (de)
AT (1) ATE66211T1 (de)
AU (1) AU600725B2 (de)
CA (1) CA1299186C (de)
DE (1) DE3772104D1 (de)
DK (1) DK172422B1 (de)
ES (1) ES2037712T3 (de)
FI (1) FI81092C (de)
GR (1) GR3002928T3 (de)
HU (1) HU197314B (de)
IE (1) IE59609B1 (de)
IL (1) IL82541A (de)
NO (1) NO166940C (de)
NZ (1) NZ220306A (de)
PT (1) PT84881B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
CA1321751C (en) * 1989-02-21 1993-08-31 Eugene C. Crichlow Mechanism mediating ruminal stasis in ruminal lactic acidosis
GB2244431A (en) * 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
FR2669030B1 (fr) * 1990-11-14 1992-12-31 Adir Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9312669D0 (en) 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
FR2735776B1 (fr) * 1995-06-22 1997-07-18 Synthelabo Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
EP1147092A1 (de) * 1999-01-18 2001-10-24 Novo Nordisk A/S Substituierte imidazole, ihre herstellung und verwendung
US6388090B2 (en) * 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
PE20011321A1 (es) * 2000-05-08 2002-01-03 Orion Corp Indanilimizadoles policiclicos nuevos con actividad adrenergica alfa 2
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
FR2839719B1 (fr) * 2002-05-16 2004-08-06 Pf Medicament Nouveaux composes imidazoliques, leur procede de preparation et leur utilisation a titre de medicaments
AU2006287070A1 (en) * 2005-08-30 2007-03-08 Queen's University At Kingston Potentiation of the therapeutic action of an opioid receptor agonist and/or inhibition or reversal of tolerance to an opioid receptoi agonists using an ultralow dose of an alpha-2 receptor antagonist
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
CN106316812A (zh) * 2009-07-24 2017-01-11 Dpx精细化学奥地利两合公司 作为中间体的二氢化茚衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908922A (nl) * 1979-12-12 1981-07-16 Akzo Nv Carboximidamide derivaten.
US4480118A (en) * 1981-01-13 1984-10-30 Sumitomo Chemical Company, Limited Carboxylic acid ester and an insecticidal and/or acaricidal composition containing the same
EP0077122B1 (de) * 1981-09-15 1986-05-07 Imperial Chemical Industries Plc Aminosubstituierte Tetraline und verwandte homocyclische Verbindungen
US4661522A (en) * 1984-05-24 1987-04-28 Akzo N.V. Cycloalkane-indene-carboximidamide derivatives
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
KR950002158B1 (ko) 1995-03-14
FI81092C (fi) 1990-09-10
FI871655A7 (fi) 1987-11-16
IE871258L (en) 1987-11-15
ES2037712T3 (es) 1993-07-01
NZ220306A (en) 1990-02-26
NO872004D0 (no) 1987-05-14
IE59609B1 (en) 1994-03-09
NO166940B (no) 1991-06-10
GR3002928T3 (en) 1993-01-25
IL82541A0 (en) 1987-11-30
DK208287A (da) 1987-11-16
US4933359A (en) 1990-06-12
PT84881B (pt) 1990-02-08
EP0247764B1 (de) 1991-08-14
DK172422B1 (da) 1998-06-08
JP2561272B2 (ja) 1996-12-04
HU197314B (en) 1989-03-28
DE3772104D1 (de) 1991-09-19
US5026868A (en) 1991-06-25
DK208287D0 (da) 1987-04-24
FI871655A0 (fi) 1987-04-15
CA1299186C (en) 1992-04-21
HUT45234A (en) 1988-06-28
NO872004L (no) 1987-11-16
AU600725B2 (en) 1990-08-23
KR880009941A (ko) 1988-10-06
AU7310287A (en) 1987-11-19
NO166940C (no) 1991-09-25
IL82541A (en) 1992-06-21
EP0247764A1 (de) 1987-12-02
JPS62289566A (ja) 1987-12-16
FI81092B (fi) 1990-05-31
PT84881A (en) 1987-06-01

Similar Documents

Publication Publication Date Title
ATE66211T1 (de) 4(5)-substituierte imidazol-derivate und zwischenverbindungen und verfahren zu ihrer herstellung.
CA1268770C (en) Preparation of imidazole derivatives
DE3774888D1 (de) Dihydrobenzofuran- und chromancarboxamid-derivate, verfahren zu ihrer herstellung und ihre verwendung als neuroleptica.
FI942882A7 (fi) Substituoituja imidatsolijohdannaisia ja niiden valmistus ja käyttö
KR890017244A (ko) 6-페닐-3-(피페라지닐알킬)-2,4-(1h,3h)-피리미딘디온 유도체, 그의 제법 및 치료에의 이용
ATE90348T1 (de) Pyrido(2,3-d>pyrimidin-derivate.
ATE37872T1 (de) Phenylinden-derivate, ihre salze, und verfahren zu ihrer herstellung.
ATE121723T1 (de) Phenylethanolamino- und phenylethanolaminomethyltetraline, verfahren zu deren herstellung zwischenprodukte davon und diese enthaltende pharmazeutische zusammensetzungen.
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.
ATE8786T1 (de) Indolobenzoxazinderivate, ihre salze, verfahren zur herstellung, ihre verwendung als arzneimittel und sie enthaltende zusammensetzungen.
IT1303123B1 (it) Derivati basici di benz(e)isoindol-1-oni e pirrolo(3,4-c)chinolin-1-oni ad attivita' 5ht3 antagonista, loro preparazione ed
DE3883891D1 (de) Benzimidazol-Derivate und Verfahren zu deren Herstellung.
ATE85054T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ATE72239T1 (de) Pyrimidinderivate und verfahren zu ihrer herstellung.
DE69204480D1 (de) Anilinderivate und Verfahren zu ihrer Herstellung.
KR910004632A (ko) 신규한 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법
CA2192596A1 (en) 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety
DE3874920D1 (de) Benzimidazol-2-one-derivate, deren salze, verfahren und zwischenprodukte zu deren herstellung, deren anwendung als arzneimittel und sie enthaltende zusammensetzungen.
ATE75468T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ES2080891T3 (es) Preparacion de derivados de amina norbornil opticamente activos.
ATE9896T1 (de) Substituierte 3-aryl-2-cycloalken-1-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE96803T1 (de) Indolo(3,2,1-de>(1,4>-oxazino(2,3,4ij>(1,5>naphthyridinderivate, verfahren zu ihrer herstellung und zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ATE49601T1 (de) Neue 11-piperazinyl-5h-imidazo(2,1c>(1,4>benzodiazepine, verfahren zu ihrer herstellung und zwischenprodukte und erstere enthaltende arzneimittel.
DE69116302D1 (de) 4-[4- oder 6-(Trifluormethyl-2-pyridinyl)]-1-piperazinyl-alkyl substituierte Laktame
DE69105108D1 (de) Substituierte N-[Phenyl-(thioxomethyl)]-morpholinderivate, Verfahren zu ihrer Herstellung, diese enthaltende Zusammensetzung und ihre Verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time